Related Articles
Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas Retraction in /etm/7/6/1803
Clinical significance of ADAM10 expression in laryngeal carcinoma
ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells
ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway
Diagnostic and prognostic value of a disintegrin and metalloproteinase‑17 in patients with gliomas